Rgene (Enzymes) Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$491K
- Investors
-
1
Rgene (Enzymes) General Information
Description
Developer of enzymes designed to use in molecular biology and genomics research. The company's products use protein engineering to improve enzyme properties for better in vitro application enabling enzyme reagents using protein engineering and data mining methods for molecular biotechnology.
Contact Information
Website
www.rgeneresearch.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Primary Industry
Biotechnology
Primary Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
+1 (617) 000-0000
Rgene (Enzymes) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Grant | 27-Mar-2015 | $491K | Completed | Startup |
Rgene (Enzymes) Patents
Rgene (Enzymes) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3430154-A4 | Hyper-thermostable lysine-mutant ssdna/rna ligases | Active | 14-Mar-2016 | 0000000000 | 0 |
| US-20190062827-A1 | Hyper-thermostable lysine-mutant ssdna/rna ligases | Inactive | 14-Mar-2016 | 0000000000 | |
| EP-3430154-B1 | Hyper-thermostable lysine-mutant ssdna/rna ligases | Active | 14-Mar-2016 | 000000000 | 0 |
| EP-3430154-A2 | Hyper-thermostable lysine-mutant ssdna/rna ligases | Active | 14-Mar-2016 | 0000000000 | |
| AU-2017218431-A1 | Multiple ligase compositions, systems, and methods | Active | 08-Feb-2016 | C12N9/93 |
Rgene (Enzymes) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institute of General Medical Sciences | Government | 000 0000 | 000000 0 |